Showing results (391-400 of 437) with videos related to
Sort By:
Pageof 44
Molecular Cancer Therapeutics|December 15, 2017
Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine CancerYan Huang, Wei Hu, Jie Huang, et al.Biorxiv : the Preprint Server for Biology|July 17, 2026
TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancerMarissa Iden, Rachel Schmidt, Rameesa Darul Amne Syed Mohammed, et al.Journal of Child Neurology|January 27, 2009
Cranial ultrasound lesions in the NICU predict cerebral palsy at age 2 years in children born at extremely low gestational ageKarl C K Kuban, Elizabeth N Allred, T Michael O'Shea, et al.Methods (San Diego, Calif.)|April 6, 2013
A new method for stranded whole transcriptome RNA-seqDavid F B Miller, Pearlly S Yan, Aaron Buechlein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to DasatinibJie Huang, Wei Hu, Justin Bottsford-Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015
XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5ATakahito Miyake, Sunila Pradeep, Sherry Y Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2013
Targeting SRC and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J Dalton, et al.Cancer Cell|July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesisMassimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.Journal of the National Cancer Institute|April 5, 2017
Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine MalignanciesRebecca A Previs, Guillermo N Armaiz-Pena, Cristina Ivan, et al.Oncotarget|December 13, 2017
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapyYasmin A Lyons, Sunila Pradeep, Sherry Y Wu, et al.Pageof 44